Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma

Published:2003-07-02 Issue:2 Volume:98 Page:337-343
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ceribelli Anna,Gridelli Cesare,De Marinis Filippo,Fabi Alessandra,Gamucci Teresa,Cortesi Enrico,Barduagni Maria,Antimi Mauro,Maione Paolo,Migliorino Maria R.,Giannarelli Diana,Cognetti Francesco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.

3. Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

4. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

5. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action;Clinical Pharmacokinetics;2020-10-16

2. A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes;F1000Research;2020-01-06

3. Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review;International Journal of Radiation Oncology*Biology*Physics;2018-01

4. A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma;Cancer Chemotherapy and Pharmacology;2014-04-01

5. SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours;British Journal of Cancer;2013-12-03